NeuroMetrix Statistics
Total Valuation
NeuroMetrix has a market cap or net worth of $9.43 million. The enterprise value is -$3.55 million.
| Market Cap | 9.43M |
| Enterprise Value | -3.55M |
Important Dates
The last earnings date was Wednesday, May 14, 2025, after market close.
| Earnings Date | May 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NeuroMetrix has 2.06 million shares outstanding. The number of shares has increased by 89.05% in one year.
| Current Share Class | 2.06M |
| Shares Outstanding | 2.06M |
| Shares Change (YoY) | +89.05% |
| Shares Change (QoQ) | +0.90% |
| Owned by Insiders (%) | 19.02% |
| Owned by Institutions (%) | 13.88% |
| Float | 1.52M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.97 |
| Forward PS | n/a |
| PB Ratio | 0.66 |
| P/TBV Ratio | 0.66 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 14.83, with a Debt / Equity ratio of 0.01.
| Current Ratio | 14.83 |
| Quick Ratio | 13.12 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -45.38% and return on invested capital (ROIC) is -29.50%.
| Return on Equity (ROE) | -45.38% |
| Return on Assets (ROA) | -27.90% |
| Return on Invested Capital (ROIC) | -29.50% |
| Return on Capital Employed (ROCE) | -57.31% |
| Revenue Per Employee | $233,295 |
| Profits Per Employee | -$600,466 |
| Employee Count | 13 |
| Asset Turnover | 0.17 |
| Inventory Turnover | 0.91 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +4.81% in the last 52 weeks. The beta is 1.01, so NeuroMetrix's price volatility has been similar to the market average.
| Beta (5Y) | 1.01 |
| 52-Week Price Change | +4.81% |
| 50-Day Moving Average | 4.40 |
| 200-Day Moving Average | 4.05 |
| Relative Strength Index (RSI) | 65.80 |
| Average Volume (20 Days) | 5,334 |
Short Selling Information
The latest short interest is 2,269, so 0.11% of the outstanding shares have been sold short.
| Short Interest | 2,269 |
| Short Previous Month | 649 |
| Short % of Shares Out | 0.11% |
| Short % of Float | 0.15% |
| Short Ratio (days to cover) | 0.52 |
Income Statement
In the last 12 months, NeuroMetrix had revenue of $3.03 million and -$7.81 million in losses. Loss per share was -$3.96.
| Revenue | 3.03M |
| Gross Profit | 1.71M |
| Operating Income | -8.20M |
| Pretax Income | -7.94M |
| Net Income | -7.81M |
| EBITDA | -8.11M |
| EBIT | -8.20M |
| Loss Per Share | -$3.96 |
Balance Sheet
The company has $13.10 million in cash and $107,352 in debt, giving a net cash position of $12.99 million or $6.31 per share.
| Cash & Cash Equivalents | 13.10M |
| Total Debt | 107,352 |
| Net Cash | 12.99M |
| Net Cash Per Share | $6.31 |
| Equity (Book Value) | 14.31M |
| Book Value Per Share | 6.98 |
| Working Capital | 14.00M |
Cash Flow
| Operating Cash Flow | -7.13M |
| Capital Expenditures | n/a |
| Free Cash Flow | -7.13M |
| FCF Per Share | -$3.46 |
Margins
Gross margin is 56.42%, with operating and profit margins of -270.43% and -257.38%.
| Gross Margin | 56.42% |
| Operating Margin | -270.43% |
| Pretax Margin | -257.38% |
| Profit Margin | -257.38% |
| EBITDA Margin | -267.33% |
| EBIT Margin | -270.43% |
| FCF Margin | n/a |
Dividends & Yields
NeuroMetrix does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -89.05% |
| Shareholder Yield | -89.05% |
| Earnings Yield | -82.75% |
| FCF Yield | -75.57% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on November 22, 2023. It was a reverse split with a ratio of 0.125:1.
| Last Split Date | Nov 22, 2023 |
| Split Type | Reverse |
| Split Ratio | 0.125:1 |
Scores
NeuroMetrix has an Altman Z-Score of -16.13 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -16.13 |
| Piotroski F-Score | 1 |